SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-052208
Filing Date
2021-04-20
Accepted
2021-04-20 07:47:44
Documents
9
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2113422d1_6k.htm 6-K 12666
2 EXHIBIT 99.1 tm2113422d1_ex99-1.htm EX-99.1 4368
3 EXHIBIT 99.2 tm2113422d1_ex99-2.htm EX-99.2 22859
4 EXHIBIT 99.3 tm2113422d1_ex99-3.htm EX-99.3 45461
5 EXHIBIT 99.4 tm2113422d1_ex99-4.htm EX-99.4 55580
6 GRAPHIC tm2113422d1_ex99-2img001.jpg GRAPHIC 10422
7 GRAPHIC tm2113422d1_ex99-2img002.jpg GRAPHIC 4931
8 GRAPHIC tm2113422d1_ex99-2img003.jpg GRAPHIC 18443
9 GRAPHIC tm2113422d1_ex99-3img001.jpg GRAPHIC 12038
  Complete submission text file 0001104659-21-052208.txt   205765
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 21836312
SIC: 2834 Pharmaceutical Preparations